Epicutaneous sensitization to house dust mite allergen requires interferon regulatory factor 4–dependent dermal dendritic cells

Journal of Allergy and Clinical Immunology

Volumn 140, Issue 5, 2017, Pages 1364-1377.e2

  Deckers, Julie ^a,b   Sichien, Dorine ^a,b   Plantinga, Maud ^a,b,c   Van Moorleghem, Justine ^a,b   Vanheerswynghels, Manon ^a,b   Hoste, Esther ^a,b   Malissen, Bernard ^d   Dombrowicz, David ^e   Guilliams, Martin ^a,b   De Bosscher, Karolien ^a,b   Lambrecht, Bart N ^a,b,c   Hammad, Hamida ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^e UNIV LILLE   (France)

Author keywords

airway inflammation; allergy; Epicutaneous sensitization; house dust mite; skin dendritic cells

Indexed keywords

HOUSE DUST MITE ALLERGEN EXTRACT; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 5; ARTHROPOD PROTEIN; CYSTEINE PROTEINASE; DERMATOPHAGOIDES PTERONYSSINUS ANTIGEN P 1; HOUSE DUST ALLERGEN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; LYMPHOCYTE ANTIGEN RECEPTOR;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMATOPHAGOIDES; EOSINOPHILIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN CELL; SKIN DEFECT; SKIN SENSITIZATION; T LYMPHOCYTE ACTIVATION; TH2 CELL; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; CELL CULTURE; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; LANGERHANS CELL; METABOLISM; PYROGLYPHIDAE; SKIN; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DERMATOPHAGOIDES; ARTHROPOD PROTEINS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DENDRITIC CELLS; HYPERSENSITIVITY; INTERFERON REGULATORY FACTORS; LANGERHANS CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PYROGLYPHIDAE; RECEPTORS, ANTIGEN, T-CELL; SKIN; TH2 CELLS;

EID: 85016504812     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.12.970     Document Type: Article

References (82)

1. Lambrecht, B.N., Hammad, H., The immunology of asthma. Nat Immunol 16 (2015), 45–56.
2. Hammad, H., Lambrecht, B.N., Barrier epithelial cells and the control of type 2 immunity. Immunity 43 (2015), 29–40.
3. Gregory, L.G., Lloyd, C.M., Orchestrating house dust mite-associated allergy in the lung. Trends Immunol 32 (2011), 402–411.
4. Kay, A.B., Allergy and allergic diseases. First of two parts. N Engl J Med 344 (2001), 30–37.
5. Carswell, F., Thompson, S.J., Percutaneous sensitisation to house dust mite may occur naturally in eczema. Int Arch Allergy Appl Immunol 82 (1987), 453–455.
6. Lambrecht, B.N., Leung, D.Y., Initiation and maintenance of allergic inflammation: team work at the interface of innate and adaptive immunity. Curr Opin Immunol 23 (2011), 769–771.
7. Palmer, C.N., Irvine, A.D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006), 441–446.
8. Rodriguez, E., Baurecht, H., Herberich, E., Wagenpfeil, S., Brown, S.J., Cordell, H.J., et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 123 (2009), 1361–1370.e7.
9. Sandilands, A., Terron-Kwiatkowski, A., Hull, P.R., O'Regan, G.M., Clayton, T.H., Watson, R.M., et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39 (2007), 650–654.
10. McLean, W.H., Palmer, C.N., Henderson, J., Kabesch, M., Weidinger, S., Irvine, A.D., Filaggrin variants confer susceptibility to asthma. J Allergy Clin Immunol 121 (2008), 1294–1295 author reply 1295-6.
11. Fallon, P.G., Sasaki, T., Sandilands, A., Campbell, L.E., Saunders, S.P., Mangan, N.E., et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41 (2009), 602–608.
12. Irvine, A.D., McLean, W.H., Leung, D.Y., Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365 (2011), 1315–1327.
13. Lambrecht, B.N., Hammad, H., Dendritic cell and epithelial cell interactions at the origin of murine asthma. Ann Am Thorac Soc 11:suppl 5 (2014), S236–S243.
14. Hammad, H., Plantinga, M., Deswarte, K., Pouliot, P., Willart, M.A., Kool, M., et al. Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 207 (2010), 2097–2111.
15. KleinJan, A., Willart, M., van Rijt, L.S., Braunstahl, G.J., Leman, K., Jung, S., et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol 118 (2006), 1117–1125.
16. Lambrecht, B.N., Hammad, H., Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu Rev Immunol 30 (2012), 243–270.
17. Plantinga, M., Guilliams, M., Vanheerswynghels, M., Deswarte, K., Branco-Madeira, F., Toussaint, W., et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38 (2013), 322–335.
18. Raymond, M., Rubio, M., Fortin, G., Shalaby, K.H., Hammad, H., Lambrecht, B., et al. Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2-mediated allergic inflammation. J Allergy Clin Immunol 124 (2009), 1333–1342.
19. Williams, J.W., Tjota, M.Y., Clay, B.S., Vander Lugt, B., Bandukwala, H.S., Hrusch, C.L., et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat Commun, 4, 2013, 2990.
20. Mesnil, C., Sabatel, C.M., Marichal, T., Toussaint, M., Cataldo, D., Drion, P.V., et al. Resident CD11b(+)Ly6C(-) lung dendritic cells are responsible for allergic airway sensitization to house dust mite in mice. PLoS One, 7, 2012, e53242.
21. Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S.H., Onai, N., Schraml, B.U., et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 14 (2014), 571–578.
22. Guilliams, M., Dutertre, C.A., Scott, C.L., McGovern, N., Sichien, D., Chakarov, S., et al. Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species. Immunity 45 (2016), 669–684.
23. Semmrich, M., Plantinga, M., Svensson-Frej, M., Uronen-Hansson, H., Gustafsson, T., Mowat, A.M., et al. Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses. Mucosal Immunol 5 (2012), 150–160.
24. Khare, A., Krishnamoorthy, N., Oriss, T.B., Fei, M., Ray, P., Ray, A., Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance. J Immunol 191 (2013), 25–29.
25. de Heer, H.J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M.A., et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 200 (2004), 89–98.
26. Henri, S., Guilliams, M., Poulin, L.F., Tamoutounour, S., Ardouin, L., Dalod, M., et al. Disentangling the complexity of the skin dendritic cell network. Immunol Cell Biol 88 (2010), 366–375.
27. Guilliams, M., Henri, S., Tamoutounour, S., Ardouin, L., Schwartz-Cornil, I., Dalod, M., et al. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol 40 (2010), 2089–2094.
28. Guilliams, M., Crozat, K., Henri, S., Tamoutounour, S., Grenot, P., Devilard, E., et al. Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. Blood 115 (2010), 1958–1968.
29. Malissen, B., Tamoutounour, S., Henri, S., The origins and functions of dendritic cells and macrophages in the skin. Nat Rev Immunol 14 (2014), 417–428.
30. Bursch, L.S., Wang, L., Igyarto, B., Kissenpfennig, A., Malissen, B., Kaplan, D.H., et al. Identification of a novel population of Langerin+ dendritic cells. J Exp Med 204 (2007), 3147–3156.
31. Ginhoux, F., Tacke, F., Angeli, V., Bogunovic, M., Loubeau, M., Dai, X.M., et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 7 (2006), 265–273.
32. Tamoutounour, S., Guilliams, M., Montanana Sanchis, F., Liu, H., Terhorst, D., Malosse, C., et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39 (2013), 925–938.
33. Schiavoni, G., Mattei, F., Borghi, P., Sestili, P., Venditti, M., Morse, H.C. 3rd, et al. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 103 (2004), 2221–2228.
34. Gao, Y., Nish, S.A., Jiang, R., Hou, L., Licona-Limon, P., Weinstein, J.S., et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 39 (2013), 722–732.
35. Kumamoto, Y., Linehan, M., Weinstein, J.S., Laidlaw, B.J., Craft, J.E., Iwasaki, A., CD301b+ dermal dendritic cells drive T helper 2 cell-mediated immunity. Immunity 39 (2013), 733–743.
36. Tussiwand, R., Everts, B., Grajales-Reyes, G.E., Kretzer, N.M., Iwata, A., Bagaitkar, J., et al. KLF4 expression in conventional dendritic cells is required for T helper 2 responses. Immunity 42 (2015), 916–928.
37. Spergel, J.M., Mizoguchi, E., Brewer, J.P., Martin, T.R., Bhan, A.K., Geha, R.S., Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101 (1998), 1614–1622.
38. Kissenpfennig, A., Henri, S., Dubois, B., Laplace-Builhe, C., Perrin, P., Romani, N., et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 (2005), 643–654.
39. Persson, E.K., Uronen-Hansson, H., Semmrich, M., Rivollier, A., Hagerbrand, K., Marsal, J., et al. IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38 (2013), 958–969.
40. Coquet, J.M., Schuijs, M.J., Smyth, M.J., Deswarte, K., Beyaert, R., Braun, H., et al. Interleukin-21-producing CD4(+) T cells promote type 2 immunity to house dust mites. Immunity 43 (2015), 318–330.
41. Strid, J., Hourihane, J., Kimber, I., Callard, R., Strobel, S., Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy 35 (2005), 757–766.
42. Strid, J., Hourihane, J., Kimber, I., Callard, R., Strobel, S., Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 34 (2004), 2100–2109.
43. Tordesillas, L., Goswami, R., Benede, S., Grishina, G., Dunkin, D., Jarvinen, K.M., et al. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest 124 (2014), 4965–4975.
44. Noti, M., Kim, B.S., Siracusa, M.C., Rak, G.D., Kubo, M., Moghaddam, A.E., et al. Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis. J Allergy Clin Immunol 133 (2014), 1390–1399.e1-6.
45. Kubo, A., Nagao, K., Amagai, M., Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 122 (2012), 440–447.
46. Hoste, E., Kemperman, P., Devos, M., Denecker, G., Kezic, S., Yau, N., et al. Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol 131 (2011), 2233–2241.
47. Georas, S.N., Rezaee, F., Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol 134 (2014), 509–520.
48. Kuo, I.H., Carpenter-Mendini, A., Yoshida, T., McGirt, L.Y., Ivanov, A.I., Barnes, K.C., et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 133 (2013), 988–998.
49. Yockey, L.J., Demehri, S., Turkoz, M., Turkoz, A., Ahern, P.P., Jassim, O., et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J Invest Dermatol 133 (2013), 2714–2721.
50. Schafer, T., Heinrich, J., Wjst, M., Adam, H., Ring, J., Wichmann, H.E., Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J Allergy Clin Immunol 104 (1999), 1280–1284.
51. Spergel, J.M., Paller, A.S., Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112:suppl (2003), S118–S127.
52. Boralevi, F., Hubiche, T., Leaute-Labreze, C., Saubusse, E., Fayon, M., Roul, S., et al. Epicutaneous aeroallergen sensitization in atopic dermatitis infants—determining the role of epidermal barrier impairment. Allergy 63 (2008), 205–210.
53. Stremnitzer, C., Manzano-Szalai, K., Starkl, P., Willensdorfer, A., Schrom, S., Singer, J., et al. Epicutaneously applied Der p 2 induces a strong TH 2-biased antibody response in C57BL/6 mice, independent of functional TLR4. Allergy 69 (2014), 741–751.
54. Shimura, S., Takai, T., Iida, H., Maruyama, N., Ochi, H., Kamijo, S., et al. Epicutaneous allergic sensitization by cooperation between allergen protease activity and mechanical skin barrier damage in mice. J Invest Dermatol 136 (2016), 1408–1417.
55. Ravichandran, S., Mortensen, L.J., DeLouise, L.A., Quantification of human skin barrier function and susceptibility to quantum dot skin penetration. Nanotoxicology 5 (2011), 675–686.
56. Chen, S.Y., Wang, X.M., Liu, Y.Q., Gao, Y.R., Liu, X.P., Li, S.Y., et al. Dimethyl sulfoxide could be a useful probe to evaluate unusual skin angioneurotic reaction and epidermal permeability. Cutan Ocul Toxicol 33 (2014), 63–69.
57. Wood, L.C., Jackson, S.M., Elias, P.M., Grunfeld, C., Feingold, K.R., Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90 (1992), 482–487.
58. Galand, C., Leyva-Castillo, J.M., Yoon, J., Han, A., Lee, M.S., McKenzie, A.N., et al. IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells. J Allergy Clin Immunol 138 (2016), 1356–1366.
59. Szalai, K., Kopp, T., Lukschal, A., Stremnitzer, C., Wallmann, J., Starkl, P., et al. Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice. Exp Dermatol 21 (2012), 842–846.
60. Stremnitzer, C., Manzano-Szalai, K., Willensdorfer, A., Starkl, P., Pieper, M., Konig, P., et al. Papain degrades tight junction proteins of human keratinocytes in vitro and sensitizes C57BL/6 mice via the skin independent of its enzymatic activity or TLR4 activation. J Invest Dermatol 135 (2015), 1790–1800.
61. Wan, H., Winton, H.L., Soeller, C., Tovey, E.R., Gruenert, D.C., Thompson, P.J., et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 104 (1999), 123–133.
62. Wan, H., Winton, H.L., Soeller, C., Taylor, G.W., Gruenert, D.C., Thompson, P.J., et al. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin Exp Allergy 31 (2001), 279–294.
63. Iida, H., Takai, T., Hirasawa, Y., Kamijo, S., Shimura, S., Ochi, H., et al. Epicutaneous administration of papain induces IgE and IgG responses in a cysteine protease activity-dependent manner. Allergol Int 63 (2014), 219–226.
64. Kubo, A., Nagao, K., Yokouchi, M., Sasaki, H., Amagai, M., External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 206 (2009), 2937–2946.
65. Shklovskaya, E., Roediger, B., Fazekas de St Groth, B., Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo. J Immunol 181 (2008), 418–430.
66. Poulin, L.F., Henri, S., de Bovis, B., Devilard, E., Kissenpfennig, A., Malissen, B., The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 204 (2007), 3119–3131.
67. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004), 279–288.
68. Bajana, S., Roach, K., Turner, S., Paul, J., Kovats, S., IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation. J Immunol 189 (2012), 3368–3377.
69. Nakajima, S., Igyarto, B.Z., Honda, T., Egawa, G., Otsuka, A., Hara-Chikuma, M., et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 129 (2012), 1048–1055.e6.
70. Igyarto, B.Z., Jenison, M.C., Dudda, J.C., Roers, A., Muller, W., Koni, P.A., et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J Immunol 183 (2009), 5085–5093.
71. Igyarto, B.Z., Haley, K., Ortner, D., Bobr, A., Gerami-Nejad, M., Edelson, B.T., et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35 (2011), 260–272.
72. Gomez de Aguero, M., Vocanson, M., Hacini-Rachinel, F., Taillardet, M., Sparwasser, T., Kissenpfennig, A., et al. Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. J Clin Invest 122 (2012), 1700–1711.
73. Bennett, C.L., van Rijn, E., Jung, S., Inaba, K., Steinman, R.M., Kapsenberg, M.L., et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169 (2005), 569–576.
74. Everts, B., Tussiwand, R., Dreesen, L., Fairfax, K.C., Huang, S.C., Smith, A.M., et al. Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12. J Exp Med 213 (2016), 35–51.
75. Martinez-Lopez, M., Iborra, S., Conde-Garrosa, R., Sancho, D., Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice. Eur J Immunol 45 (2015), 119–129.
76. de Kleer, I., Kool, M., de Bruijn-de Jong, M., Willart, M., van Moorleghem, J., Plantinga, M., et al. Early postnatal hyperactivity of the IL33 pathway promotes type 2 immunity to house dust mite by boosting dendritic cells and innate lymphoid type 2 cells. Immunity 45 (2016), 1285–1298.
77. Ivanov, S., Scallan, J.P., Kim, K.W., Werth, K., Johnson, M.W., Saunders, B.T., et al. CCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability. J Clin Invest 126 (2016), 1581–1591.
78. Vander Lugt, B., Khan, A.A., Hackney, J.A., Agrawal, S., Lesch, J., Zhou, M., et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol 15 (2014), 161–167.
79. Kumamoto, Y., Hirai, T., Wong, P.W., Kaplan, D.H., Iwasaki, A., CD301b+ dendritic cells suppress T follicular helper cells and antibody responses to protein antigens. eLife, 5, 2016.
80. Dullaers, M., Schuijs, M.J., Willart, M., Fierens, K., Van Moorleghem, J., Hammad, H., et al. House dust mite-driven asthma and allergen-specific T cells depend on B cells when the amount of inhaled allergen is limiting. J Allergy Clin Immunol 140 (2017), 76–88.e7.
81. Hondowicz, B.D., An, D., Schenkel, J.M., Kim, K.S., Steach, H.R., Krishnamurty, A.T., et al. Interleukin-2-dependent allergen-specific tissue-resident memory cells drive asthma. Immunity 44 (2016), 155–166.
82. Rydnert, F., Lundberg, K., Greiff, L., Lindstedt, M., Circulating CD1c(+) DCs are superior at activating Th2 responses upon Phl p stimulation compared with basophils and pDCs. Immunol Cell Biol 92 (2014), 557–560.